Comparison of the price of Laos version of dacomitinib with other versions

The Lao version of Dacomitinib (Dacomitinib) is produced by Laos Lucius Pharmaceuticals, and its price is relatively economical. According to market information, the price of the Lao version of dacomitinib is approximately 1,000 yuan, which makes it a choice for many patients, especially when the price of the original drug is higher. Compared with the price of the original drug, the Lao version of dacomitinib has a significant price advantage, reducing the financial burden for patients who require long-term treatment.

Original drugs are more expensive. In China, the original version of dacomitinib has been launched and is included in the medical insurance reimbursement. The original drug specification is 15mg*30 tablets and the price is 5680 yuan. After reimbursement from medical insurance, patients need to pay approximately 1,300 yuan, which is an acceptable price for many patients. However, in Europe, the price of the original drug is even more expensive. The price of 45mg*30 tablets is 24,000 yuan, which makes many patients unable to afford the high cost of treatment.

The Lao version of generic drugs is not only low-priced, but also has similar efficacy to the original drug. The quality of generic drugs is usually produced according to the standards of the original drugs, and the ingredients and efficacy are basically the same. Lucius Pharmaceuticals, the manufacturer of the Lao version of dacomitinib, ensures that its generic version meets strict quality control requirements so patients can feel more confident when taking it. Compared with original drugs, patients can significantly reduce drug costs while maintaining therapeutic effects by choosing the Lao version of generic drugs.

In summary, the price of the Lao version of dacomitinib is very affordable, especially suitable for patients with limited financial conditions. Compared with the original drug, it is more cost-effective and provides patients with a more feasible treatment option. In areas without medical insurance coverage or with low medical insurance reimbursement rates, patients may consider purchasing generic drugs through formal channels to reduce financial pressure without affecting treatment effects.

Reference materials:https://www.pfizer.com/products/product-detail/vizimpro